BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE

Clinical trial NCT06538077 · RECRUITING

Trial details

NCT number: NCT06538077
Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatic Encephalopathy Decompensated Cirrhosis Minimal Hepatic Encephalopathy

Start date: 2025-02-01
Primary completion: 2026-08-01
Enrollment: 336

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.